The Neuro’s drug discovery initiative supports research by developing assays shared with the scientific community
In the past 40 years, the model of drug discovery used by the pharmaceutical industry, while proving successful for some applications, has produced very little for neurodegenerative diseases.
“We have to ask if there is a better way to find therapies that will modify the course of diseases, slowing or stopping them from progressing. While Open Science is not going to solve every problem, it will be a big part of the solution.”“Take Parkinson’s disease, for instance: there have been zero new disease modifying medications developed in the last 40 years, despite hundreds of millions of dollars being invested in research,” says Dr. Edward Fon, whose lab focuses on molecular and cellular research into Parkinson’s disease. “We have to ask if there is a better way to find therapies that will modify the course of diseases, slowing or stopping them from progressing. While Open Science is not going to solve every problem, it will be a big part of the solution.”
The Neuro’s drug discovery initiative aims to support research by developing assays that investigate different aspects of target cells and sharing these assays with colleagues around the world. The main vehicle for sharing assays is The Neuro’s Induced Pluripotent Stem Cell (iPSC) platform, developed recently with seed money generously donated by Sebastian van Berkom and Ghislaine Saucier.
“We can provide industry-standard assays researchers can use to test compounds,” says Thomas Durcan, another Parkinson’s researcher who manages the iPSC platform. “In collaboration with researchers at Université Laval, we reprogram blood cells from patients with neurological diseases into stem cells, and then transform the stem cells into the type of neural cells most impacted in neuropathology.”
This gives researchers the ability to compare normal and diseased states of the cells within one patient, which has long been possible for some diseases but is a novel advance for neurological research. The Centre for Drug Research and Development, a Canadian nonprofit organization that aims to speed the translation of discoveries into therapies, and the international Structural Genomics Consortium have both formed partnerships with the Tanenbaum Open Science Institute to use the iPSC platform.
“If we can identify potential compounds for targeting diseases such as Parkinson’s and share them so they can be screened and tested throughout the scientific community, we can accelerate the rate of discovery,” says Dr. Fon. “Other researchers can benefit from the resources we develop, and the chances of 100 laboratories finding something useful is much greater than that of one lab working alone. If we can come up with something leading to treatment for Parkinson’s disease, that would be an incredible payback.”
Learn more: Accelerating drug discovery with Open Science
The Latest on: Open Science
via Google News
The Latest on: Open Science
- Rewarding excellence in Open Scienceon November 20, 2020 at 8:37 am
After examining dozens of impressive submissions from across the globe, a committee of judges has finalized the winning entries for The Neuro Open Science in Action Prizes. The finalists are all ...
- CZI awards $4.7 million for open source software and organizations advancing open scienceon November 19, 2020 at 11:51 am
The Chan Zuckerberg Initiative announced $3 million in funding for open source software projects representing some of the strongest computational foundations of modern biomedicine, and $1.7 million to ...
- All Saints Third Grade Open Science Morningon November 19, 2020 at 8:58 am
One of your neighbors posted in Schools. Click through to read what they have to say. (The views expressed in this post are the author’s own.) ...
- AiCure Launches Open Science Framework to Advance Digital Biomarker Development at CNS Summit 2020on October 31, 2020 at 2:55 pm
"AiCure's OpenDBM opens this black box. Through an open science framework, we hope to unleash the potential of digital biomarkers to not only safeguard the success of a trial and understanding of ...
- NSF funds K-State open science research projecton October 24, 2020 at 4:28 pm
MANHATTAN, Kan. (WIBW) - The National Science Foundation is funding an open science research project from Kansas State University computer science professor, Pascal Hitzler. Kansas State ...
- World Science and Technology Development Forum to open in Novemberon October 23, 2020 at 9:05 pm
The event will also highlight five sub-forums focusing on the digital economy, innovation of small and medium-sized technology businesses, open science and cooperation in open source innovation ...
- World science forum to open in Beijing next monthon October 23, 2020 at 2:09 am
China will host the second World Science and Technology Development Forum in Beijing from Nov 8 to 9 to facilitate mutual trust and cooperation and promote open, ethical and inclusive practices in ...
- Silicon Therapeutics Supports Five Researchers Through Open Science Fellows Programon October 21, 2020 at 6:51 am
“Open science remains paramount to our culture at Silicon Therapeutics,” said Woody Sherman, Ph.D., chief scientific officer. “This class of Open Science Fellows was carefully selected from ...
- Silicon Therapeutics Supports Five Researchers Through Open Science Fellows Programon October 21, 2020 at 4:35 am
Silicon Therapeutics, a privately-held, fully integrated drug design, discovery and development company focused on small molecule therapeutics, today is pleased to introduce the 2020 members of the ...
via Bing News